A Crucial Factor in the Development of Therapeutic Approaches: Microgenderome?

Abstract

A close association of microbiota in human health continues to emerge. Microbiota has been implicated in autoimmune disorders such as type I diabetes mellitus, inflammatory bowel disease, rheumatoid arthritis and multiple sclerosis.1 This is pointing out that early-life microbial exposure could be linked to later-life susceptibility to immune-mediated disorders.